Regions Financial Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Regions Financial Corp’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,312	Closed	-$604K	–	873
2022 Q4	$604K	Sell	5,312 -33	-0.6%	-$2.74K	0.01%	565
2022 Q3	$331K	Sell	5,345 -1,691	-24%	-$118K	﹤0.01%	665
2022 Q2	$561K	Buy	7,036 +149	+2%	+$14.1K	0.01%	572
2022 Q1	$725K	Buy	6,887 +241	+4%	+$23.5K	0.01%	560
2021 Q4	$716K	Buy	6,646 +7	+0.1%	+$764	0.01%	563
2021 Q3	$727K	Buy	6,639 +462	+7%	+$48K	0.01%	546
2021 Q2	$578K	Buy	6,177 +1,412	+30%	+$130K	0.01%	580
2021 Q1	$439K	Buy	4,765 +1,884	+65%	+$159K	﹤0.01%	606
2020 Q4	$211K	Buy	+2,881	New	+$214K	﹤0.01%	781
2020 Q2	–	Sell	-11,624	Closed	-$344K	–	889
2020 Q1	$344K	Sell	11,624 -4,066	-26%	-$138K	﹤0.01%	560
2019 Q4	$568K	Sell	15,690 -264	-2%	-$8.09K	0.01%	509
2019 Q3	$434K	Buy	+15,954	New	+$413K	﹤0.01%	553
2019 Q2	–	Sell	-19,570	Closed	-$517K	–	1956
2019 Q1	$517K	Sell	19,570 -1,815	-8%	-$43K	0.01%	525
2018 Q4	$418K	Sell	21,385 -99	-0.5%	-$1.94K	0.01%	550
2018 Q3	$421K	Sell	21,484 -5,544	-21%	-$105K	﹤0.01%	609
2018 Q2	$448K	Sell	27,028 -4,485	-14%	-$68.4K	0.01%	581
2018 Q1	$447K	Sell	31,513 -9,031	-22%	-$133K	0.01%	603
2017 Q4	$592K	Sell	40,544 -29,962	-42%	-$421K	0.01%	537
2017 Q3	$894K	Sell	70,506 -1,554	-2%	-$19.8K	0.01%	456
2017 Q2	$855K	Buy	72,060 +28,862	+67%	+$359K	0.01%	479
2017 Q1	$639K	Sell	43,198 -12,779	-23%	-$207K	0.01%	606
2016 Q4	$905K	Sell	55,977 -39,951	-42%	-$724K	0.01%	537
2016 Q3	$1.74M	Buy	+95,928	New	+$1.87M	0.02%	327
2015 Q3	–	Sell	-40,623	Closed	-$1.41M	–	951
2015 Q2	$1.41M	Sell	40,623 -37,032	-48%	-$1.13M	0.02%	422
2015 Q1	$2.02M	Buy	+77,655	New	+$1.42M	0.03%	323

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Regions Financial Corp's HZNP Position: Q1 2023 in Review

Regions Financial Corp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 5,312 shares — an estimated $604K sold.

Regions Financial Corp first reported a position in HZNP in Q1 2015 and held it in 25 quarters. The position peaked at $2.02M in Q1 2015. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Regions Financial Corp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Regions Financial Corp sold 5,312 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $604K.
Regions Financial Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 25 quarters.
Regions Financial Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.02M in Q1 2015.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Regions Financial Corp's 13F filing for Q1 2023, filed 12 May 2023.